Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 20 May 2026 for FIREBRICK PHARMA LIMITED, €8,221.
Filing timeline
BuySaleStephen Francis Goodall Date of last notice 10 October 2024 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Stephen Francis Goodall Date of last notice 10 October 2024 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust: trading record in brief
Our data holds just one disclosure by Stephen Francis Goodall Date of last notice 10 October 2024 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust, dated 20 May 2026, reporting an open-market purchase worth €8,221 in Firebrick Pharma Limited. Further filings will be added here. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen Francis Goodall Date of last notice 10 October 2024 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 110,000 shares@ A$0.046100.0% of flowShareASXISIN AU0000197352ASX:2924-03092313-6A1326384Canonical exit: 18 Aug 2026 (T+90)
1 of 1 declaration